Pfizer and UMC strike agreement to enhance healthcare services' quality
In a significant move aimed at improving access to high-quality healthcare services in Vietnam, Pfizer, one of the world's leading innovative biopharmaceutical companies, has signed a three-year Memorandum of Understanding (MoU) with the University Medical Centre HCM City (UMC) on August 14 [2].
The partnership, which focuses on organizing specialized training programmes in antibiotics, antifungals, vaccines, cardiovascular diseases, and cancer, aims to drive positive and sustainable value in the healthcare sector [1]. Le Khac Baou, vice director of UMC, believes this collaboration will equip teams with a solid foundation of knowledge and foster research and innovation [3].
The MoU also aims to enhance infectious disease prevention and treatment capacity, sharing medical knowledge between experts and institutions, and raising public awareness about common preventable infectious diseases and chronic conditions such as cardiovascular diseases and cancer [1].
Darrell Oh, general director of Pfizer, reaffirmed the company's commitment to supporting Vietnam's healthcare system through positive innovation. As part of the collaboration, Pfizer is planning specialized knowledge exchange sessions to equip healthcare professionals with the knowledge and skills needed to master advancements in medical science [4].
The partnership will expand engagement with expert networks to address the practical needs of hospitals in southern provinces, marking a strategic step towards improving healthcare quality not just in Vietnam, but across the region [1]. The ultimate goal of this partnership is to change the lives of patients and communities in Vietnam [5].
Pfizer has a long history of collaborating with healthcare providers, governments, and communities for over 170 years to expand access to reliable, affordable healthcare worldwide [6]. This partnership with UMC is a testament to their continued dedication to this cause.
References: 1. Pfizer and University Medical Centre HCM City Partner to Improve Healthcare Quality in Vietnam 2. Pfizer and University Medical Centre HCM City Sign MoU to Improve Access to High-Quality Healthcare Services in Vietnam 3. UMC HCM City and Pfizer Collaborate to Strengthen Medical Capabilities 4. Pfizer and UMC HCM City to Organize Specialised Training Programmes 5. Pfizer and UMC HCM City: A Partnership for Change 6. Pfizer's History of Collaboration
- This collaboration between Pfizer and University Medical Centre HCM City will boost research and innovation in areas like vaccines, cancer, and cardiovascular diseases.
- The partnership seeks to improve health and wellness by implementing therapies and treatments for various medical conditions, including cancer.
- The MoU signed by Pfizer and UMC aims to enhance the labor force in the healthcare sector, focusing on advancements in medicine and science.
- Darrell Oh, general director of Pfizer, emphasized the company's dedication to supporting the Vietnamese government's efforts in improving healthcare quality and access through this partnership.
- The partnership will contribute to the development of AI in healthcare, as Pfizer plans to conduct specialized knowledge exchange sessions on medical-related advancements.
- This partnership will not only address the practical needs of hospitals in Vietnam but will also extend its impact to healthcare systems across the region.
- The strategic alliance between Pfizer and UMC will focus on nutrition and cardiovascular health, aiming to improve the overall health of communities in Vietnam.
- By focusing on preventable infectious diseases and chronic conditions like cancer and cardiovascular diseases, this partnership aims to save lives and contribute positively to the healthcare sector.
